Patent ID: 11919892
Assignee: KING FAISAL UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 4:
5. A method of treating a microbial infection in a patient comprising administering to a patient in need thereof a therapeutically effective amount of the 2-(benzo[d]thiazol-2-yl)-N′-(245-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio) acetoxy)acetimidamide compound of claim 1; wherein the microbial infection is caused by one or more gram positive bacteria, one or more gram negative bacteria, one or more fungi, or a combination thereof; wherein the one or more gram positive bacteria are Bacillus cereus, Staphylococcus aureus, or a combination thereof; wherein the one or more gram negative bacteria are Pseudomonas aeruginosa, Escherichia coli, or a combination thereof; and wherein the one or more fungi are Aspergillus flavus, Chrysosporium keratinophilum, or a combination thereof.